Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.94
Delayed Data
As of Jun 28
 +0.0203 / +2.21%
Today’s Change
0.82
Today|||52-Week Range
2.59
-25.40%
Year-to-Date
7 Biotech Stocks that are Buys Right Now
Jun 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.92
Today’s open0.95
Day’s range0.91 - 0.96
Volume74,007
Average volume (3 months)216,172
Market cap$53.5M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+73.27%
Earnings growth (this year)-88.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.97%
P/E ratioNM
Price/Sales3.69
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...0.000.00%
XOMAXOMA Corp+0.00+0.84%
RNNRexahn Pharmaceutica...+0.01+3.14%
MTEXMannatech Inc+0.40+2.00%
Data as of 3:09pm ET, 06/28/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$19.0M
Annual profit (last year)-$15.0M
Net profit margin-78.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs